TRIM21 and myopathy: However, since both our cases were negative for selected MSAs including anti-Jo-1, it is unclear whether the positive testing for anti-Ro52 may be associated with inflammatory myopathy and ILD or possibly overlapping with additional, nondetected antibodies more specific for inflammatory myopathy associated with this serious complication.